Birmingham, West Midlands -- (SBWIRE) -- 12/26/2013 -- Value Penny Stocks issues special report on First Niagara Financial Group Inc. (NASDAQ:FNFG), Globalstar, Inc. (OTCMKTS:GSAT), Galena Biopharma Inc (NASDAQ:GALE), VIVUS, Inc. (NASDAQ:VVUS).
First Niagara Financial Group Inc. (NASDAQ:FNFG) opened its last trade at the price of $10.46. Its closing price was $10.53 after gaining 0.96% for the day. The company traded with the total volume of 1,081,866 shares, while its average trading volume remained 3.05 million shares. The beta of this stock stands at 1.08. First Niagara Financial Group, Inc. operates as the bank holding company for First Niagara Bank, N.A. that provides retail and commercial banking, and other financial services to individuals, families, and businesses.
For How Long FNFG will Fight for Profitability? Read This Trend Analysis report
Globalstar, Inc. (OTCMKTS:GSAT) percentage change plunged -0.54% to close at $1.85 with the total traded volume of 1.07 million shares, along with average volume of 3.82 million shares. The 52 week range of the stock remained $0.25 - $2.06, while its day lowest price was $1.81. The share price hit the day highest price of $1.86. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational, emergency response, and other applications.
Has GSAT Found The Bottom And Ready To Gain Momentum? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) traded on volume of 1,053,104 shares in the last session against average volume of 6.58 million shares. The company started its trading session with the price of $4.06 and closed at $4.00. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
How Should Investors Trade GALE Now? Don’t Miss out a Special Trend Analysis
VIVUS, Inc. (NASDAQ:VVUS) started its last trading session with the price of $9.26 and closed at $9.32. The stock traded with total volume of 1,052,336 shares, while the average trading volume remained 1.72 million shares. The beta value of this stock stands at 1.33. Day range for the stock was $9.25 - $9.47. VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health.
What VVUS’s Charts Are Signaling for Traders? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)